Synthesis and preliminary evaluation of [C-11]-(-)-phenylephrine as a functional heart neuronal PET agent
Synthesis and preliminary evaluation of [C-11]-(-)-phenylephrine as a functional heart neuronal PET agent
复制标题
DOI:
10.1016/0969-8051(96)00057-1
复制
发表时间:
1996-07-01
影响因子:
3.1
通讯作者:
Wieland, DM
中科院分区:
文献类型:
--
作者:
DelRosario, RB;Jung, YW;Wieland, DM
The in vivo behavior of (-)-[C-11]phenylephrine (PHEN) is compared with the structurally similar but monoamine oxidase (MAO)-resistant analog (-)-[C-11]-m-hydroxyephedrine (HED), which is an established heart neuronal marker. The chiral synthesis of PHEN has been achieved by direct methylation of (-)-m-octopamine with either (CH3I)-C-11 Or (CF3SO3CH3)-C-11. These synthetic methods produced PHEN with a specific activity ranging from 500-1000 Ci/mmol, in a radiochemical yield of >50% (EOS) and with an enantiomeric purity of 94-96%. Biodistribution studies indicate the initial uptake of PHEN in rat heart is approximately half that of HED. Following PHEN injection, radioactivity egresses from the rat heart rapidly, with 50% washout occurring from 5 to 60 min. LIED washout over this interval was less than 20%. The heart neuronal selectivity determined by desipramine blockade of the amine neuronal transporter was 75-77% compared to 92-95% for LIED. Ring-labeled (-)-[H-3]phenylephrine gave tissue-to-blood concentration ratios and heart clearance times very similar to PHEN. Rats pretreated with the MAO A inhibitor clorgyline showed higher levels of activity in the heart: at 15 and 60 min. Tandem PET studies with PHEN and HED in the closed-chest dog provided excellent heart images with both tracers.